Revenio Group Oyj (CHIX:REG1VH) Beta: -0.0309 (As of Jun. 26, 2026)


CHIX:REG1VH Revenio Group Oyj CHIX:REG1VH
80 GF Score
Price €16.47
GF Value €36.95
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Revenio Group Oyj Beta?

Revenio Group Oyj CHIX:REG1VH 80 Beta is -0.0309 as of Jun. 26, 2026. GuruFocus rates CHIX:REG1VH with a GF Score™ of 80/100 and a GF Value™ of €36.95 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Revenio Group Oyj's Beta is -0.0309.


Revenio Group Oyj  (CHIX:REG1Vh) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Revenio Group Oyj Beta Related Terms


Revenio Group Oyj Beta Historical Data

* Premium members only.

The historical data trend for Revenio Group Oyj's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revenio Group Oyj Beta Chart

Revenio Group Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.47 -0.07 0.26

Revenio Group Oyj Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 0.06 0.25 0.26 0.43

CHIX:REG1VH vs ABT, SYK, MDT: Beta Comparison

For the Medical Devices subindustry, Revenio Group Oyj's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revenio Group Oyj Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's Beta distribution charts can be found below:

* The bar in red indicates where Revenio Group Oyj's Beta falls into.


CHIX:REG1VH
80GF Score
Revenio Group Oyj CHIX:REG1VH
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revenio Group Oyj Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.0309 mean?
Revenio Group Oyj (CHIX:REG1VH) has a Beta of -0.0309 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Revenio Group Oyj and its competitors.
Is Revenio Group Oyj's Beta too high?
Revenio Group Oyj's current Beta is -0.0309. Overall, Revenio Group Oyj has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's Beta compare to ABT and SYK?
Revenio Group Oyj's Beta of -0.0309 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Revenio Group Oyj and its competitors. Revenio Group Oyj's current Beta is -0.0309. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Based on GuruFocus' analysis, Revenio Group Oyj (CHIX:REG1VH) is currently considered Significantly Undervalued. The stock's GF Value™ is €36.95, compared to a current price of €16.47 — trading 55.4% below its estimated fair value. The current Beta is -0.0309. Revenio Group Oyj's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Revenio Group Oyj (CHIX:REG1VH), the current Beta is -0.0309 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revenio Group Oyj (CHIX:REG1VH) Overvalued in 2026?

Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued. The current stock price of €16.47 is trading 55.4% below its estimated GF Value™ of €36.95. GuruFocus considers Revenio Group Oyj to be Significantly Undervalued.

Key valuation signals for CHIX:REG1VH:

  • Beta: -0.0309
  • GF Value™: €36.95 vs. price of €16.47 (55.4% below fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the CHIX:REG1VH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Revenio Group Oyj Business Description

Address Harkahaankuja 7, Vantaa, FIN, 01730
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
80GF Score

Get the complete analysis for CHIX:REG1VH

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.47
Price
€36.95
GF Value